J Gen Virol Try IJSEM Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 86 (2005), 285-295; DOI 10.1099/vir.0.80458-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Figures
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eickhoff, J. E.
Right arrow Articles by Cotten, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eickhoff, J. E.
Right arrow Articles by Cotten, M.
Agricola
Right arrow Articles by Eickhoff, J. E.
Right arrow Articles by Cotten, M.
© 2005 Society for General Microbiology

NF-{kappa}B activation can mediate inhibition of human cytomegalovirus replication

Jan Eike Eickhoff and Matt Cotten

Axxima Pharmaceuticals AG, Max-Lebsche-Platz 32, 81377 Munich, Germany

Correspondence
Matt Cotten
matt.cotten{at}axxima.com

The activation of NF-{kappa}B has long been considered a positive factor for human cytomegalovirus (HCMV) replication. The HCMV immediate-early promoter, the initial transcriptional element in the HCMV replication cycle, is activated by the transcription factor NF-{kappa}B, and several HCMV gene products have been demonstrated to activate this transcription factor. However, the role of NF-{kappa}B in the full replication cycle of the virus has not been carefully examined. A series of experiments that demonstrate an important inhibitory role of NF-{kappa}B for HCMV replication in fibroblasts is presented here. Using both genetic and pharmaceutical methods, it was shown that blocking NF-{kappa}B activation in cell culture does not inhibit HCMV replication, but rather leads to a modest increase in replication. Two cytokines inhibitory for HCMV, tumour necrosis factor-{alpha} and interferon-{gamma}, no longer inhibit HCMV when NF-{kappa}B activation is blocked. Furthermore, forced expression of the NF-{kappa}B activating I{kappa}B kinase {beta} (IKK{beta}), but not a kinase inactive mutant, also inhibits HCMV replication. In addition, it was shown that NF-{kappa}B signalling is essential for the production of an anti-viral factor in the supernatant of HCMV-infected fibroblasts, and identified interferon-{beta} as this factor. Thus, the role of NF-{kappa}B in fibroblasts is to activate a host defence against HCMV.

Supplementary material available in JGV Online.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. T. Nogalski, J. P. Podduturi, I. B. DeMeritt, L. E. Milford, and A. D. Yurochko
The Human Cytomegalovirus Virion Possesses an Activated Casein Kinase II That Allows for the Rapid Phosphorylation of the Inhibitor of NF-{kappa}B, I{kappa}B{alpha}
J. Virol., May 15, 2007; 81(10): 5305 - 5314.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. T. Taylor and W. A. Bresnahan
Human Cytomegalovirus IE86 Attenuates Virus- and Tumor Necrosis Factor Alpha-Induced NF{kappa}B-Dependent Gene Expression.
J. Virol., November 1, 2006; 80(21): 10763 - 10771.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Gustems, E. Borst, C. A. Benedict, C. Perez, M. Messerle, P. Ghazal, and A. Angulo
Regulation of the Transcription and Replication Cycle of Human Cytomegalovirus Is Insensitive to Genetic Elimination of the Cognate NF-{kappa}B Binding Sites in the Enhancer
J. Virol., October 1, 2006; 80(19): 9899 - 9904.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 by the Society for General Microbiology.